Claritev Corporation (CTEV)
Healthcare
Health Information Services
22.70 $
-3.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Claritev Corporation (CTEV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 33.8% of the shares are freely tradable; institutional investors hold 91.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
91.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
33.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
11.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
17Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| H&F Corporate Investors VIII, Ltd. | 22.81 | 3,887,858 | +0.0 | 03/31/2026 |
| Ares Management LLC | 10.93 | 1,863,105 | +0.0 | 03/31/2026 |
| Arini Captial Management Ltd | 9.00 | 1,534,687 | +2.0 | 03/31/2026 |
| PUBLIC INVESTMENT FUND | 7.52 | 1,281,250 | +0.0 | 03/31/2026 |
| Beach Point Capital Management LP | 4.67 | 795,346 | +5.3 | 03/31/2026 |
| BlackRock Inc | 3.45 | 588,003 | +4.7 | 03/31/2026 |
| Vanguard Group Inc | 3.43 | 584,470 | +12.9 | 12/31/2025 |
| CPV Partners, LLC | 2.91 | 495,258 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.52 | 430,068 | +0.0 | 03/31/2026 |
| Caspian Capital Partners, L.P. | 2.09 | 356,250 | +42.5 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.